110 related articles for article (PubMed ID: 12483529)
21. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
22. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
23. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
24. Activation of the nuclear factor kappa B pathway following ischemia-reperfusion of the murine testis.
Lysiak JJ; Bang HJ; Nguyen QA; Turner TT
J Androl; 2005; 26(1):129-35. PubMed ID: 15611577
[TBL] [Abstract][Full Text] [Related]
25. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
Nakagawa Y; Akao Y
Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
[TBL] [Abstract][Full Text] [Related]
26. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.
Faumont N; Le Clorennec C; Teira P; Goormachtigh G; Coll J; Canitrot Y; Cazaux C; Hoffmann JS; Brousset P; Delsol G; Feuillard J; Meggetto F
Cancer Res; 2009 Jun; 69(12):5177-85. PubMed ID: 19491276
[TBL] [Abstract][Full Text] [Related]
27. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
28. Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway.
Feng G; Ohmori Y; Chang PL
Carcinogenesis; 2006 Jan; 27(1):43-52. PubMed ID: 16000401
[TBL] [Abstract][Full Text] [Related]
29. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
[TBL] [Abstract][Full Text] [Related]
30. T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
Li X; Liu J; Park JK; Hamilton TA; Rayman P; Klein E; Edinger M; Tubbs R; Bukowski R; Finke J
Cancer Res; 1994 Oct; 54(20):5424-9. PubMed ID: 7923175
[TBL] [Abstract][Full Text] [Related]
31. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
32. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.
Garbati MR; Alço G; Gilmore TD
Cancer Lett; 2010 May; 291(2):237-45. PubMed ID: 19948376
[TBL] [Abstract][Full Text] [Related]
33. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
Petrenko O; Ischenko I; Enrietto PJ
Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides.
Romano MF; Lamberti A; Bisogni R; Tassone P; Pagnini D; Storti G; Del Vecchio L; Turco MC; Venuta S
Gene Ther; 2000 Jul; 7(14):1234-7. PubMed ID: 10918492
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the NF-kappaB p50 dimer interface by diversity screening.
Hart DJ; Speight RE; Sutherland JD; Blackburn JM
J Mol Biol; 2001 Jul; 310(3):563-75. PubMed ID: 11439024
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.
Hoffmann A; Leung TH; Baltimore D
EMBO J; 2003 Oct; 22(20):5530-9. PubMed ID: 14532125
[TBL] [Abstract][Full Text] [Related]
37. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
Epinat JC; Dvorin EL; Gilmore TD
Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
[TBL] [Abstract][Full Text] [Related]
38. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
Gilmore TD
Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
[TBL] [Abstract][Full Text] [Related]
39. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.
Haery L; Lugo-Picó JG; Henry RA; Andrews AJ; Gilmore TD
Mol Cancer; 2014 Feb; 13():29. PubMed ID: 24529102
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a homologue of the Rel/NF-kappaB transcription factor from a beetle, Allomyrina dichotoma.
Sagisaka A; Tanaka H; Furukawa S; Yamakawa M
Biochim Biophys Acta; 2004 May; 1678(2-3):85-93. PubMed ID: 15157734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
